181 related articles for article (PubMed ID: 38076977)
1. Testing SIPA1L2 as a modifier of CMT1A using mouse models.
Murray GC; Hines TJ; Tadenev ALD; Xu I; Züchner S; Burgess RW
bioRxiv; 2023 Dec; ():. PubMed ID: 38076977
[TBL] [Abstract][Full Text] [Related]
2. Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A.
Tao F; Beecham GW; Rebelo AP; Svaren J; Blanton SH; Moran JJ; Lopez-Anido C; Morrow JM; Abreu L; Rizzo D; Kirk CA; Wu X; Feely S; Verhamme C; Saporta MA; Herrmann DN; Day JW; Sumner CJ; Lloyd TE; Li J; Yum SW; Taroni F; Baas F; Choi BO; Pareyson D; Scherer SS; Reilly MM; Shy ME; Züchner S;
Ann Neurol; 2019 Mar; 85(3):316-330. PubMed ID: 30706531
[TBL] [Abstract][Full Text] [Related]
3. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
4. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
[TBL] [Abstract][Full Text] [Related]
5. SARM1 knockout does not rescue neuromuscular phenotypes in a Charcot-Marie-Tooth disease Type 1A mouse model.
Moss KR; Johnson AE; Bopp TS; Yu AT; Perry K; Chung T; Höke A
J Peripher Nerv Syst; 2022 Mar; 27(1):58-66. PubMed ID: 35137510
[TBL] [Abstract][Full Text] [Related]
6. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.
Matsuda N; Ootsuki K; Kobayashi S; Nemoto A; Kubo H; Usami SI; Kanani K
BMC Neurol; 2021 Jun; 21(1):243. PubMed ID: 34171997
[TBL] [Abstract][Full Text] [Related]
7. A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.
Stavrou M; Kagiava A; Choudury SG; Jennings MJ; Wallace LM; Fowler AM; Heslegrave A; Richter J; Tryfonos C; Christodoulou C; Zetterberg H; Horvath R; Harper SQ; Kleopa KA
J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35579942
[TBL] [Abstract][Full Text] [Related]
8. AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cells.
Yoshioka Y; Taniguchi JB; Homma H; Tamura T; Fujita K; Inotsume M; Tagawa K; Misawa K; Matsumoto N; Nakagawa M; Inoue H; Tanaka H; Okazawa H
Commun Med (Lond); 2023 Nov; 3(1):170. PubMed ID: 38017287
[TBL] [Abstract][Full Text] [Related]
9. Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice.
Bai Y; Treins C; Volpi VG; Scapin C; Ferri C; Mastrangelo R; Touvier T; Florio F; Bianchi F; Del Carro U; Baas FF; Wang D; Miniou P; Guedat P; Shy ME; D'Antonio M
Mol Neurobiol; 2022 Jul; 59(7):4159-4178. PubMed ID: 35501630
[TBL] [Abstract][Full Text] [Related]
10. MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy.
Kohl B; Fischer S; Groh J; Wessig C; Martini R
Am J Pathol; 2010 Mar; 176(3):1390-9. PubMed ID: 20093502
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Charcot-Marie-Tooth 1A and nondystrophic myotonia due to PMP22 duplication and SCN4A pathogenic variants: a case report.
Nan H; Wu Y; Cui S; Sun H; Wang J; Li Y; Meng L; Nagasaka T; Wu L
BMC Neurol; 2022 Jan; 22(1):17. PubMed ID: 34996390
[TBL] [Abstract][Full Text] [Related]
12. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
Roa BB; Garcia CA; Lupski JR
Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
[TBL] [Abstract][Full Text] [Related]
13. An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease.
Kinter J; Lazzati T; Schmid D; Zeis T; Erne B; Lützelschwab R; Steck AJ; Pareyson D; Peles E; Schaeren-Wiemers N
Neurobiol Dis; 2013 Jan; 49():221-31. PubMed ID: 22940629
[TBL] [Abstract][Full Text] [Related]
14. The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed
Michailidou I; Vreijling J; Rumpf M; Loos M; Koopmans B; Vlek N; Straat N; Agaser C; Kuipers TB; Mei H; Baas F; Fluiter K
Curr Res Neurobiol; 2023; 4():100077. PubMed ID: 36926597
[TBL] [Abstract][Full Text] [Related]
15. Electroceutical approach ameliorates intracellular PMP22 aggregation and promotes pro-myelinating pathways in a CMT1A in vitro model.
Intisar A; Woo H; Kang HG; Kim WH; Shin HY; Kim MY; Kim YS; Mo YJ; Lee YI; Kim MS
Biosens Bioelectron; 2023 Mar; 224():115055. PubMed ID: 36630746
[TBL] [Abstract][Full Text] [Related]
16. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
[TBL] [Abstract][Full Text] [Related]
17. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
18. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
Lee JS; Lee JY; Song DW; Bae HS; Doo HM; Yu HS; Lee KJ; Kim HK; Hwang H; Kwak G; Kim D; Kim S; Hong YB; Lee JM; Choi BO
Nucleic Acids Res; 2020 Jan; 48(1):130-140. PubMed ID: 31713617
[TBL] [Abstract][Full Text] [Related]
19. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of peripheral myelin protein 22 for nerve compression and neural regeneration: a review.
Hui-Chou HG; Hashemi SS; Hoke A; Dellon AL
J Reconstr Microsurg; 2011 Jan; 27(1):67-74. PubMed ID: 20976668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
